CN1249052C - 作为hiv逆转录酶抑制剂的吡唑衍生物 - Google Patents

作为hiv逆转录酶抑制剂的吡唑衍生物 Download PDF

Info

Publication number
CN1249052C
CN1249052C CNB028111974A CN02811197A CN1249052C CN 1249052 C CN1249052 C CN 1249052C CN B028111974 A CNB028111974 A CN B028111974A CN 02811197 A CN02811197 A CN 02811197A CN 1249052 C CN1249052 C CN 1249052C
Authority
CN
China
Prior art keywords
methyl
alkyl
group
heterocyclic radical
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028111974A
Other languages
English (en)
Chinese (zh)
Other versions
CN1527829A (zh
Inventor
布莱恩·威廉姆·迪莫克
阿德里安·利亚姆·吉尔
菲利普·斯蒂芬·琼斯
凯文·爱德华·博丹·帕克斯
马丁·约翰·帕拉特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1527829A publication Critical patent/CN1527829A/zh
Application granted granted Critical
Publication of CN1249052C publication Critical patent/CN1249052C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
CNB028111974A 2001-06-04 2002-05-29 作为hiv逆转录酶抑制剂的吡唑衍生物 Expired - Fee Related CN1249052C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0113524.3 2001-06-04
GBGB0113524.3A GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives

Publications (2)

Publication Number Publication Date
CN1527829A CN1527829A (zh) 2004-09-08
CN1249052C true CN1249052C (zh) 2006-04-05

Family

ID=9915841

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028111974A Expired - Fee Related CN1249052C (zh) 2001-06-04 2002-05-29 作为hiv逆转录酶抑制剂的吡唑衍生物

Country Status (17)

Country Link
US (1) US6538015B1 (enExample)
EP (1) EP1401826B1 (enExample)
JP (1) JP4088249B2 (enExample)
KR (1) KR100627532B1 (enExample)
CN (1) CN1249052C (enExample)
AT (1) ATE357439T1 (enExample)
AU (1) AU2002325221B2 (enExample)
BR (1) BR0210158A (enExample)
CA (1) CA2448058C (enExample)
DE (1) DE60219009T2 (enExample)
DK (1) DK1401826T3 (enExample)
ES (1) ES2282446T3 (enExample)
GB (1) GB0113524D0 (enExample)
MX (1) MXPA03011199A (enExample)
PT (1) PT1401826E (enExample)
WO (1) WO2002100853A1 (enExample)
ZA (1) ZA200308781B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
JP4993407B2 (ja) 2004-08-04 2012-08-08 大正製薬株式会社 トリアゾール誘導体
WO2006072833A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
EP1988083B1 (en) 2006-02-03 2014-04-02 Taisho Pharmaceutical Co., Ltd. Triazole derivative
RU2395499C2 (ru) * 2006-02-06 2010-07-27 Тайсо Фармасьютикал Ко., Лтд. Ингибитор связывания сфингозин-1-фосфата
PL2057125T3 (pl) 2006-08-16 2011-09-30 Hoffmann La Roche Nienukleozydowe inhibitory odwrotnej transkryptazy
BRPI0813404A2 (pt) 2007-06-22 2014-12-30 Hoffmann La Roche Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo
SI2177512T1 (sl) 2007-08-01 2012-06-29 Taisho Pharmaceutical Co Ltd Inhibitor vezave S1P1
RU2495878C2 (ru) 2007-12-21 2013-10-20 Ф.Хоффманн-Ля Рош Аг Гетероциклические антивирусные соединения
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
EP2295038B1 (en) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Solid dispersion comprising an anti-HIV agent
ES2528646T3 (es) * 2010-05-20 2015-02-11 Bayer Intellectual Property Gmbh Procedimiento para la fabricación de 1-alquil-3-difluorometil-5-hidroxipirazoles
JP5722891B2 (ja) 2010-07-15 2015-05-27 大日本住友製薬株式会社 ピラゾール化合物
WO2014074628A1 (en) * 2012-11-08 2014-05-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds for treating hiv and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627423A4 (en) 1992-01-22 1995-02-15 Nissan Chemical Ind Ltd SUBSTITUTED PYRAZOLE DERIVATIVES AND BACTERICIDES FOR AGRICULTURE AND GARDENING.
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
DK0786455T3 (da) 1994-09-26 2004-03-29 Shionogi & Co Imidazolderivater
US5698495A (en) 1995-11-15 1997-12-16 Zeneca Limited Herbicidal substituted pyrazole compounds
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases

Also Published As

Publication number Publication date
PT1401826E (pt) 2007-06-19
AU2002325221B2 (en) 2008-07-31
JP4088249B2 (ja) 2008-05-21
CN1527829A (zh) 2004-09-08
WO2002100853A1 (en) 2002-12-19
MXPA03011199A (es) 2004-02-26
US6538015B1 (en) 2003-03-25
DE60219009T2 (de) 2007-12-13
EP1401826A1 (en) 2004-03-31
ATE357439T1 (de) 2007-04-15
JP2004532276A (ja) 2004-10-21
ZA200308781B (en) 2005-02-11
CA2448058C (en) 2008-12-23
GB0113524D0 (en) 2001-07-25
CA2448058A1 (en) 2002-12-19
DK1401826T3 (da) 2007-07-30
EP1401826B1 (en) 2007-03-21
BR0210158A (pt) 2004-06-08
DE60219009D1 (de) 2007-05-03
KR20040003050A (ko) 2004-01-07
KR100627532B1 (ko) 2006-09-21
ES2282446T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
CN1249052C (zh) 作为hiv逆转录酶抑制剂的吡唑衍生物
CN1072669C (zh) 苯并咪唑化合物及其用作gabaa受体复合物调节器的用途
CN1128617C (zh) 含三唑衍生物的药物组合物的制备方法
CN1156477C (zh) 作为p38蛋白激酶的抑制剂的烷基氨基-取代的双环氮杂环类化合物
CN1036456C (zh) 氨基取代的吡唑
CN1158256C (zh) 吡咯烷衍生物-ccr-3受体拮抗剂
CN1045088C (zh) 用作pnp抑制剂的嘌呤和鸟嘌呤化合物
CN1070856C (zh) 噻唑衍生物
CN1378544A (zh) 取代的唑系化合物
CN1261277A (zh) 新的取代咪唑化合物
CN1047497A (zh) 抗炎药氨基苯酚衍生物
CN1976919A (zh) 作为erk蛋白激酶抑制剂的吡咯化合物、它们的合成和中间体
CN1665789A (zh) 二氨基嘧啶酰胺衍生物
CN1639159A (zh) N－氨基乙酰基－吡咯烷－2－腈和它们作为ddp－iv抑制剂的用途
CN1582284A (zh) 氨基嘧啶类和吡啶类化合物
CN1759114A (zh) 作为细胞因子抑制剂的杂环n－芳基甲酰胺
CN1344160A (zh) 用作生长激素促分泌剂的杂环芳族化合物
CN1498212A (zh) 新螺三环衍生物及其作为磷酸二酯酶-7抑制剂的应用
CN1845921A (zh) 金刚烷和氮杂双环－辛烷及壬烷衍生物、其制备方法及其作为dpp－iv抑制剂的用途
CN1077571C (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CN1503673A (zh) 消炎药
CN1608050A (zh) 哌嗪衍生物
CN1469865A (zh) 用于治疗病毒性疾病的吡唑衍生物
CN1349524A (zh) 血管紧张肽原酶抑制剂
CN1788002A (zh) 作为钠通道阻滞剂的联芳基取代的三唑化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060405